These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20826125)

  • 1. Happy birthday cell penetrating peptides: already 20 years.
    Brasseur R; Divita G
    Biochim Biophys Acta; 2010 Dec; 1798(12):2177-81. PubMed ID: 20826125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.
    Heitz F; Morris MC; Divita G
    Br J Pharmacol; 2009 May; 157(2):195-206. PubMed ID: 19309362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1988-2018: Thirty years of drug smuggling at the nano scale. Challenges and opportunities of cell-penetrating peptides in biomedical research.
    Gallo M; Defaus S; Andreu D
    Arch Biochem Biophys; 2019 Jan; 661():74-86. PubMed ID: 30447207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating peptides: from molecular mechanisms to therapeutics.
    Morris MC; Deshayes S; Heitz F; Divita G
    Biol Cell; 2008 Apr; 100(4):201-17. PubMed ID: 18341479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-based nanoparticle for ex vivo and in vivo drug delivery.
    Crombez L; Morris MC; Deshayes S; Heitz F; Divita G
    Curr Pharm Des; 2008; 14(34):3656-65. PubMed ID: 19075741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
    Li H; Tsui TY; Ma W
    Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
    Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
    Elife; 2021 Oct; 10():. PubMed ID: 34713805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating peptides: a useful tool for the delivery of various cargoes into cells.
    Böhmová E; Machová D; Pechar M; Pola R; Venclíková K; Janoušková O; Etrych T
    Physiol Res; 2018 Oct; 67(Suppl 2):S267-S279. PubMed ID: 30379549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery.
    Wang F; Wang Y; Zhang X; Zhang W; Guo S; Jin F
    J Control Release; 2014 Jan; 174():126-36. PubMed ID: 24291335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake.
    Deshayes S; Konate K; Aldrian G; Crombez L; Heitz F; Divita G
    Biochim Biophys Acta; 2010 Dec; 1798(12):2304-14. PubMed ID: 20541523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
    Feni L; Neundorf I
    Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
    Shi NQ; Qi XR; Xiang B; Zhang Y
    J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
    Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
    J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Primary Mechanism of Cellular Internalization for a Short Cell- Penetrating Peptide as a Nano-Scale Delivery System.
    Liu BR; Huang YW; Korivi M; Lo S-Y; Aronstam RS; Lee H-J
    Curr Pharm Biotechnol; 2017; 18(7):569-584. PubMed ID: 28828981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
    Walrant A; Cardon S; Burlina F; Sagan S
    Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.